Enhanced levels of microRNA-125b in vascular smooth muscle cells of diabetic db/db mice lead to increased inflammatory gene expression by targeting the histone methyltransferase Suv39h1. - Wikidata - wikimedia - TriplyDB

Enhanced levels of microRNA-125b in vascular smooth muscle cells of diabetic db/db mice lead to increased inflammatory gene expression by targeting the histone methyltransferase Suv39h1.

Enhanced levels of microRNA-125b in vascular smooth muscle cells of diabetic db/db mice lead to increased inflammatory gene expression by targeting the histone methyltransferase Suv39h1.

http://www.wikidata.org/entity/Q34237731

about

Nitric oxide, oxidative stress, and p66Shc interplay in diabetic endothelial dysfunction The short and long of noncoding sequences in the control of vascular cell phenotypes Differential Response to High Glucose in Skin Fibroblasts of Monozygotic Twins Discordant for Type 1 Diabetes microRNA in the development of diabetic complications.Epigenetics: an expanding new piece of the stroke puzzle Suv39h1 mediates AP-2α-dependent inhibition of C/EBPα expression during adipogenesis.Elevated expression levels of miR-143/5 in saphenous vein smooth muscle cells from patients with Type 2 diabetes drive persistent changes in phenotype and function.Angiotensin II-regulated microRNA 483-3p directly targets multiple components of the renin-angiotensin system.MicroRNAs overexpressed in growth-restricted rat skeletal muscles regulate the glucose transport in cell culture targeting central TGF-β factor SMAD4 Diabetes alters activation and repression of pro- and anti-inflammatory signaling pathways in the vasculature.Emerging roles of the myocardin family of proteins in lipid and glucose metabolism.Circulating microRNA signature in non-alcoholic fatty liver disease: from serum non-coding RNAs to liver histology and disease pathogenesis Dietary alleviation of maternal obesity and diabetes: increased resistance to diet-induced obesity transcriptional and epigenetic signatures.Epigenetic mechanisms in diabetic vascular complications.MicroRNAs in β-cell biology, insulin resistance, diabetes and its complications Signature of circulating microRNAs as potential biomarkers in vulnerable coronary artery disease Epigenetics: deciphering its role in diabetes and its chronic complications.Epigenetic mechanisms in diabetic complications and metabolic memory.MicroRNA changes in human arterial endothelial cells with senescence: relation to apoptosis, eNOS and inflammation.Epigenetic mechanisms of endothelial dysfunction in type 2 diabetes.Myocardin-Related Transcription Factor A Epigenetically Regulates Renal Fibrosis in Diabetic Nephropathy.Clinical significance and expression of microRNA in diabetic patients with erectile dysfunction.Small RNA sequencing reveals microRNAs that modulate angiotensin II effects in vascular smooth muscle cells Long-lasting partnership between insulin resistance and endothelial dysfunction: role of metabolic memory.Vascular smooth muscle cell phenotypic plasticity: focus on chromatin remodelling.MicroRNAs and diabetic complications Genome-wide DNA methylation analysis identifies a metabolic memory profile in patient-derived diabetic foot ulcer fibroblasts Metabolic stress in the myocardium: adaptations of gene expression.Epigenetic modifications and diabetic nephropathy.H3K9me3 Inhibition Improves Memory, Promotes Spine Formation, and Increases BDNF Levels in the Aged Hippocampus.Regulation of Vascular Smooth Muscle Cell Dysfunction Under Diabetic Conditions by miR-504 Impact of high glucose and proteasome inhibitor MG132 on histone H2A and H2B ubiquitination in rat glomerular mesangial cells.High glucose concentration induces endothelial cell proliferation by regulating cyclin-D2-related miR-98.MicroRNAs: potential mediators and biomarkers of diabetic complications.Epigenetic modifications in the pathogenesis of diabetic nephropathy Downregulation of microRNA‑34b is responsible for the elevation of blood pressure in spontaneously hypertensive rats.Role of microRNAs in diabetes and its cardiovascular complications.MiR-125 in normal and malignant hematopoiesis.Micro-RNAs in inflammatory diseases and as a link between inflammation and cancer.Epigenetic regulation of vascular smooth muscle cell function in atherosclerosis.

P2860

Q26830607-8F97152B-5EC5-4BD2-8B44-5713DE866B88 Q28080857-BBCF7663-02BF-40D2-9714-85892145073F Q30300141-92356029-3119-423B-BE55-86187AE85395 Q30353835-26701274-0D13-445F-A4D3-254606D37B52 Q33352309-61FB86F0-D085-4570-938F-43D970190DCE Q33743624-59465CF2-8572-42D5-A631-7017CF124D86 Q34001116-B40A35AF-2BBB-42CB-AFAB-B0FD5190193A Q34150434-4FFCB68D-375D-4F13-97D3-8A50004667EC Q34233643-E1F251A1-2EEF-4BF8-B450-1292BE195ABB Q34350546-E6D75DCD-F089-4901-BDE0-E9532F5019C6 Q34521411-DB6321CF-1AB1-4CC5-B6E6-D22CECBF082E Q34778143-A497DE29-E2AF-4D2B-BEF4-5D671CF91BA0 Q34796061-0E8E9A3E-BDDE-4292-B084-622EC7922367 Q34986508-37253326-4158-4FD3-925C-72EE0DB11674 Q35063263-3582FF2E-0D44-4F9B-971B-CDE16CE68AE3 Q35067334-FACE7876-E2A1-4223-870A-6E5D529622A8 Q35068854-12286757-120A-49B6-B26D-7B0E5E65118C Q35071700-9FC8059B-546C-4159-8488-3CDAC83A2274 Q35631669-1E3687DF-202E-412F-80F8-5AD97FEF1F91 Q35645997-57A4B181-C5CA-4E55-8AB1-73D349582F72 Q35790594-3E941E7E-E6A1-417A-958B-1A433ABEBA89 Q35802924-0C151E3F-646C-4E5A-BEAB-62763DF8F5E8 Q35939806-AF9D1B60-DAA4-41F0-AF75-D4A48B48E5F0 Q35978075-1BAF3D65-0D74-41F3-8E5A-D090C1C6D9B4 Q36073494-93D8E928-EE19-4BC2-B129-0E6B797F7106 Q36094855-2B5B28B1-F1B0-4218-BB6D-366FC85BEADF Q36214096-492D3D8C-8DE2-42BE-B7E2-39F2119F0065 Q36328486-3456845A-F60A-4293-99F9-28E9BADF03B8 Q36471772-142B0625-8068-459D-BA77-9C86DED4803F Q36718683-E60A9CCF-D31F-49C8-B8E7-E2DA819CB224 Q36849525-8C266DA1-6F44-4B52-9FC0-489657F99E5C Q36853565-DA25D29C-FA8B-494E-82BB-998080190CE9 Q36942373-962920EB-B4B6-4695-8D1F-C56C71A798CD Q37146727-355BA820-8B77-43AD-B651-62E3368B9FB7 Q37158080-D4999E7F-185E-4EF2-BD17-1FB869B6797E Q37722155-0FBEA3CE-8383-424F-8EFD-9ECE1B69E959 Q37953896-4A5956D8-E912-4857-A3CD-3E8F01502B6F Q37997926-8B167D81-0BB1-4C65-8FA5-5EF037D7A907 Q38082379-9E0B81FF-F2D5-4E12-A335-507F49BC6D87 Q38083011-989E62C5-7ECD-4DB3-8079-A79C404B8E52

P2860

Enhanced levels of microRNA-125b in vascular smooth muscle cells of diabetic db/db mice lead to increased inflammatory gene expression by targeting the histone methyltransferase Suv39h1.

http://www.wikidata.org/entity/Q34237731

description

2010 nî lūn-bûn

@nan

2010 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年学术文章

@wuu

2010年学术文章

@zh-cn

2010年学术文章

@zh-hans

2010年学术文章

@zh-my

2010年学术文章

@zh-sg

2010年學術文章

@yue

name

Enhanced levels of microRNA-12 ...... one methyltransferase Suv39h1.

@ast

Enhanced levels of microRNA-12 ...... one methyltransferase Suv39h1.

@en

Enhanced levels of microRNA-12 ...... one methyltransferase Suv39h1.

@nl

type

label

Enhanced levels of microRNA-12 ...... one methyltransferase Suv39h1.

@ast

Enhanced levels of microRNA-12 ...... one methyltransferase Suv39h1.

@en

Enhanced levels of microRNA-12 ...... one methyltransferase Suv39h1.

@nl

prefLabel

Enhanced levels of microRNA-12 ...... one methyltransferase Suv39h1.

@ast

Enhanced levels of microRNA-12 ...... one methyltransferase Suv39h1.

@en

Enhanced levels of microRNA-12 ...... one methyltransferase Suv39h1.

@nl

P1433

Q34237731-B4739DFA-6675-4ED9-A252-4253CC9C764B

P1476

Q34237731-54C2DFDB-1BEB-4D80-A59D-222A4930E9D0

P2093

Q34237731-14365AB1-9944-4422-B5BB-BD4C16424EF0

Q34237731-4A23C818-2C9F-45F2-9DDE-8EA3F38FDD09

Q34237731-4D0CA766-3333-4231-932D-859FE3028851

Q34237731-7FFDFC2E-E7E3-45B1-A68D-33BABDCA5A2E

Q34237731-8A4430D4-FA84-4286-BB63-212DC497CF13

P2860

Q34237731-00918601-07F3-4FA5-8B5D-20AD4C4E7564

Q34237731-0E0EE5EC-0A36-421F-ACB3-F50972CD89FE

Q34237731-0EB07723-62CF-463C-95FB-04276AA25714

Q34237731-0EFC98A5-90BA-431D-8DD2-F81A1C97244E

Q34237731-0F8A4B78-9AC6-4B10-80D1-98C88B6FFA08

Q34237731-1699EBE4-6AD8-46B8-B67F-4E32F045F637

Q34237731-1CD25D92-92AA-4B63-BE26-7C4BE02731ED

Q34237731-1E3CC08E-7D46-4DBC-AD2F-C5D9D23FE863

Q34237731-24FAE945-9059-44BF-814A-76C97E5BD35A

Q34237731-2F086E8B-2CE7-43AA-BD41-5ECD8EB02A1A

P304

Q34237731-F4FD13E7-CCD5-499D-8DDC-1803C4FCE1B3

P31

Q34237731-1A7715DC-8262-4A27-84F2-AB0199370714

P356

Q34237731-85B46F62-C68F-4FFC-8966-E73C5D0E8D5E

P407

Q34237731-2A5B8530-3DCB-4DD3-8D7E-CC6A23A3EFA9

P433

Q34237731-40E9CA0D-8420-4ADC-BBCC-3285C80CD441

P478

Q34237731-A3F26360-9444-4CE2-ABCE-AB5C5F2ABF96

P50

Q34237731-FE56BE3B-2977-4170-8FF6-3D54530BF957

P577

Q34237731-27384668-212E-4E98-88D1-6F7057ED7EB3

P5875

Q34237731-FC166C79-29D6-4F90-9A94-792A20CC1CF5

P698

Q34237731-A37FFD0E-94D2-4E9A-9AE5-C247A724286D

P921

Q34237731-0D32BC4A-8765-4918-A8E4-C3AC19734B51

Q34237731-99F32795-9B76-4E8A-9921-36E41C6B8330

P932

Q34237731-63AA76BD-4732-49C4-A3EF-9F581C71F2E6

P356

P1433

P1476

Enhanced levels of microRNA-12 ...... tone methyltransferase Suv39h1

@en

P2093

Linda Lanting

http://www.w3.org/2001/XMLSchema#string

Louisa M Villeneuve

http://www.w3.org/2001/XMLSchema#string

Marpadga A Reddy

http://www.w3.org/2001/XMLSchema#string

Mei Wang

http://www.w3.org/2001/XMLSchema#string

Rama Natarajan

http://www.w3.org/2001/XMLSchema#string

P2860

Intensive Diabetes Treatment and Cardiovascular Disease in Patients with Type 1 Diabetes

miR-145 and miR-143 regulate smooth muscle cell fate and plasticity

MicroRNAs: target recognition and regulatory functions

MicroRNAs miR-143 and miR-145 modulate cytoskeletal dynamics and responsiveness of smooth muscle cells to injury

A necessary role of miR-221 and miR-222 in vascular smooth muscle cell proliferation and neointimal hyperplasia

Oncomirs - microRNAs with a role in cancer

Biogenesis of small RNAs in animals

Biochemistry and molecular cell biology of diabetic complications

Diabetes-associated sustained activation of the transcription factor nuclear factor-kappaB

MicroRNA-26a targets the histone methyltransferase Enhancer of Zeste homolog 2 during myogenesis

P304

2904-2915

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2337/DB10-0208

http://www.w3.org/2001/XMLSchema#string

P407

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

59

http://www.w3.org/2001/XMLSchema#string

P50

P577

2010-08-10T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

45603465

http://www.w3.org/2001/XMLSchema#string

P698

20699419

http://www.w3.org/2001/XMLSchema#string

P921

P932

2963550

http://www.w3.org/2001/XMLSchema#string